Coumarins from free ortho-hydroxy cinnamates by Heck-Matsuda arylations: a scalable total synthesis of (R)-tolterodine.
暂无分享,去创建一个
[1] Xinmei Fu,et al. Palladium-catalyzed oxidative Heck coupling reaction for direct synthesis of 4-arylcoumarins using coumarins and arylboronic acids. , 2012, The Journal of organic chemistry.
[2] F. Felpin,et al. Recent advances in the Heck–Matsuda reaction in heterocyclic chemistry , 2011 .
[3] C. R. Correia,et al. Evolution And Synthetic Applications Of The Heck-matsuda Reaction: The Return Of Arenediazonium Salts To Prominence , 2011 .
[4] C. R. Correia,et al. Stereoselective synthesis of unsymmetrical β,β-diarylacrylates by a Heck-Matsuda reaction: versatile building blocks for asymmetric synthesis of β,β-diphenylpropanoates, 3-aryl-indole, and 4-aryl-3,4-dihydro-quinolin-2-one and formal synthesis of (-)-indatraline. , 2011, The Journal of organic chemistry.
[5] B. Lipshutz,et al. Asymmetric conjugate reductions of coumarins. A new route to tolterodine and related coumarin derivatives. , 2009, Organic letters.
[6] J. Yun,et al. Enantioselective synthesis of (R)-tolterodine via CuH-catalyzed asymmetric conjugate reduction. , 2009, The Journal of organic chemistry.
[7] C. Deutsch,et al. CuH-catalyzed reactions. , 2008, Chemical reviews.
[8] Sungdae Park,et al. Reduction of ethyl benzoylacetate and selective protection of 2 -(3 -hydroxy-1-phenylpropyl)-4-methylphenol : A new and facile synthesis of tolterodine , 2007 .
[9] A. Charette,et al. Catalytic Enantioselective Reduction of β,β-Disubstituted Vinyl Phenyl Sulfones by Using Bisphosphine Monoxide Ligands† , 2007 .
[10] F. Ulgheri,et al. Enantioselective synthesis of (s)- and (R)-tolterodine by asymmetric hydrogenation of a coumarin derivative obtained by a Heck reaction. , 2007, The Journal of organic chemistry.
[11] J. Carretero,et al. Catalytic Asymmetric Conjugate Reduction of β,β‐Disubstituted α,β‐Unsaturated Sulfones , 2007 .
[12] Mark E. Scott,et al. Aryl-aryl bond formation by transition-metal-catalyzed direct arylation. , 2007, Chemical reviews.
[13] J. Carretero,et al. Catalytic asymmetric conjugate reduction of beta,beta-disubstituted alpha,beta-unsaturated sulfones. , 2007, Angewandte Chemie.
[14] M. Moreno-Mañas,et al. Diazonium salts as substrates in palladium-catalyzed cross-coupling reactions. , 2006, Chemical Reviews.
[15] Jinlong Wu,et al. One‐Pot Wittig Reactions in Aqueous Media: A Rapid and Environmentally Benign Synthesis of α,β‐Unsaturated Carboxylic Esters and Nitriles , 2006 .
[16] Kelin Li,et al. Sequential Pd(II)-Pd(0) catalysis for the rapid synthesis of coumarins. , 2005, The Journal of organic chemistry.
[17] G. Fabrizi,et al. Synthesis of Coumarins in a Molten n‐Bu4NOAc/n‐Bu4NBr Mixture through a Domino Heck Reaction/Cyclization Process , 2005 .
[18] M. Różalski,et al. Cytotoxic effects, alkylating properties and molecular modelling of coumarin derivatives and their phosphonic analogues. , 2003, European journal of medicinal chemistry.
[19] M. Lemaire,et al. Aryl-aryl bond formation one century after the discovery of the Ullmann reaction. , 2002, Chemical reviews.
[20] A. Wein,et al. Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review. , 2002, European urology.
[21] U. Jonas,et al. Tolterodine: an overview , 2001, World Journal of Urology.
[22] R O'Kennedy,et al. Comparison of the tetrazolium salt assay for succinate dehydrogenase with the cytosensor microphysiometer in the assessment of compound toxicities. , 1999, Analytical biochemistry.
[23] P. Andersson,et al. Asymmetric Total Synthesis of (+)-Tolterodine, a New Muscarinic Receptor Antagonist, via Copper-Assisted Asymmetric Conjugate Addition of Aryl Grignard Reagents to 3-Phenyl-prop-2-enoyl-oxazolidinones , 1998 .
[24] C. Siegers,et al. Antitumor-activities of coumarin, 7-hydroxy-coumarin and its glucuronide in several human tumor cell lines. , 1998, Research communications in molecular pathology and pharmacology.
[25] D. Egan,et al. Studies on the cytostatic and cytotoxic effects and mode of action of 8-nitro-7-hydroxycoumarin. , 1997, Cancer letters.